263 related articles for article (PubMed ID: 31848379)
1. Assessing the therapeutic potential of Graptopetalum paraguayense on Alzheimer's disease using patient iPSC-derived neurons.
Wu PC; Fann MJ; Tran TT; Chen SC; Devina T; Cheng IH; Lien CC; Kao LS; Wang SJ; Fuh JL; Tzeng TT; Huang CY; Shiao YJ; Wong YH
Sci Rep; 2019 Dec; 9(1):19301. PubMed ID: 31848379
[TBL] [Abstract][Full Text] [Related]
2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
3. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.
Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM
Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.
Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K
Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485
[TBL] [Abstract][Full Text] [Related]
5. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
[TBL] [Abstract][Full Text] [Related]
6. iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease.
Kondo T; Imamura K; Funayama M; Tsukita K; Miyake M; Ohta A; Woltjen K; Nakagawa M; Asada T; Arai T; Kawakatsu S; Izumi Y; Kaji R; Iwata N; Inoue H
Cell Rep; 2017 Nov; 21(8):2304-2312. PubMed ID: 29166618
[TBL] [Abstract][Full Text] [Related]
7. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
8. Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability.
Muratore CR; Zhou C; Liao M; Fernandez MA; Taylor WM; Lagomarsino VN; Pearse RV; Rice HC; Negri JM; He A; Srikanth P; Callahan DG; Shin T; Zhou M; Bennett DA; Noggle S; Love JC; Selkoe DJ; Young-Pearse TL
Stem Cell Reports; 2017 Dec; 9(6):1868-1884. PubMed ID: 29153990
[TBL] [Abstract][Full Text] [Related]
9. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
[TBL] [Abstract][Full Text] [Related]
10. Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.
Wang C; Ward ME; Chen R; Liu K; Tracy TE; Chen X; Xie M; Sohn PD; Ludwig C; Meyer-Franke A; Karch CM; Ding S; Gan L
Stem Cell Reports; 2017 Oct; 9(4):1221-1233. PubMed ID: 28966121
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
12. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
13. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
Sahlgren Bendtsen KM; Hall VJ
Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
[TBL] [Abstract][Full Text] [Related]
14. High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy.
Cheng C; Reis SA; Adams ET; Fass DM; Angus SP; Stuhlmiller TJ; Richardson J; Olafson H; Wang ET; Patnaik D; Beauchamp RL; Feldman DA; Silva MC; Sur M; Johnson GL; Ramesh V; Miller BL; Temple S; Kosik KS; Dickerson BC; Haggarty SJ
Sci Rep; 2021 Aug; 11(1):17029. PubMed ID: 34426604
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.
Ando K; Maruko-Otake A; Ohtake Y; Hayashishita M; Sekiya M; Iijima KM
PLoS Genet; 2016 Mar; 12(3):e1005917. PubMed ID: 27023670
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease Neurons.
van der Kant R; Langness VF; Herrera CM; Williams DA; Fong LK; Leestemaker Y; Steenvoorden E; Rynearson KD; Brouwers JF; Helms JB; Ovaa H; Giera M; Wagner SL; Bang AG; Goldstein LSB
Cell Stem Cell; 2019 Mar; 24(3):363-375.e9. PubMed ID: 30686764
[TBL] [Abstract][Full Text] [Related]
17. Yuan‑zhi‑san inhibits tau protein aggregation in an Aβ
Li B; Xie PJ; Hao YW; Guo Y; Yu JR; Gong DY; Guo J; Zeng JH; Zhang Y
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604685
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
19. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
[TBL] [Abstract][Full Text] [Related]
20. Modeling amyloid beta and tau pathology in human cerebral organoids.
Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
